Literature DB >> 20695192

[Tumor necrosis factor in uterine leiomyomas at various stages of tumor growth].

Małgorzata Wolańska1, Ewelina Taudul, Emilia Bańkowska-Guszczyn, Maciej Kinalski.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the expression of tumor necrosis factors -alpha and beta (TNF), their receptor and content in human uterine leiomyomas at various stages of tumor growth.
MATERIAL AND METHODS: Studies were performed on human myometrium and uterine leiomyomas of various weights (small: less than 10 g and large: more than 100 g). Presence of both growth factors and their receptor was detected by Western Immunoblotting technique. The content of TNF-alpha was evaluated by immunoenzymatic method (ELISA).
RESULTS: Changes in the expression of tumor necrosis factors and their receptor and difference in content of TNF-alpha during the tumor growth were found.
CONCLUSIONS: Myometrium conversion into leiomyoma and an increase in its mass is accompanied by changes in the expression and contents TNF and TNF RI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695192

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  3 in total

1.  TNF-α serum levels are elevated in women with clinically symptomatic uterine fibroids.

Authors:  Michał Ciebiera; Marta Włodarczyk; Małgorzata Wrzosek; Cezary Wojtyła; Męczekalski Błażej; Grażyna Nowicka; Krzysztof Łukaszuk; Grzegorz Jakiel
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

Review 2.  The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.

Authors:  Michał Ciebiera; Marta Włodarczyk; Magdalena Zgliczyńska; Krzysztof Łukaszuk; Błażej Męczekalski; Christopher Kobierzycki; Tomasz Łoziński; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

Review 3.  Recent Advances of Pyridinone in Medicinal Chemistry.

Authors:  Shibo Lin; Chun Liu; Xiaotian Zhao; Xiao Han; Xuanhao Li; Yongqin Ye; Zheyu Li
Journal:  Front Chem       Date:  2022-03-23       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.